ReviewJournal of assisted reproduction and genetics2025
Sperm abnormality: Differential expression of microRNAs.
Review in Journal of assisted reproduction and genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Adult male fertility requires continuous production of sperm through the spermatogenesis process involving the correct timing of regulatory signals to spermatogonial stem cells (SSCs) to support continuous gamete generation. MicroRNAs (miRNAs) modulate gene expression post-transcriptionally and are shown to regulate various biological pathways in both humans and animal models. miRNAs in Sertoli cells and germ cells respond to regulatory signals and downregulate or upregulate required mRNAs and proteins that function in different pathways to support successful spermatogenesis. In addition, differential expression of miRNAs in sperm and seminal plasma of men with sperm disorders and normozoospermia is reported. However, the role of miRNAs in the pathogenesis of patients with sperm disorders and its mechanisms have not been comprehensively studied. The aim of this review is to describe the mechanisms through which the dysregulation of miRNAs can lead to male infertility. Further, the possibility of using miRNAs as diagnostic and therapeutic targets is discussed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.